FindTrial
Sign In

A single-center observational study of analgesic and sedative effects and safety evaluation of butorphanol in patients with heart failure

Analgesic and sedative effects and safety evaluation of butorphanol in patients with heart failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049937
Enrollment
Unknown
Registered
2021-08-14
Start date
2021-09-10
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac insufficiency

Interventions

Intervention group:butorphanol
control group:morphine

Sponsors

Tongji Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Age range: 18 ~ 80 years; Clinical diagnosis of acute left heart failure; No previous history of mental illness or nervous system disease; Informed consent of patients and their families.

Exclusion criteria

Exclusion criteria: Pregnancy and lactation, persistent hypotension, history of opioid allergy, opioid addiction, type II respiratory failure, neuromuscular disease, severe hypoxia ( PaO2/ FiO2 <150), cardiogenic shock.

Design outcomes

Primary

MeasureTime frame
Sedation-Agitation Scale;cardiac output;systemic vascular resistance;—

Countries

China

Contacts

Public ContactLi Yongsheng

Tongji Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology

ysli@tjh.tjmu.edu.cn+86 13971668789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026